COLLABORATIVE RESEARCH, DEVELOPMENT, COMMERCIALIZATION
AND LICENSE AGREEMEN
BETWEEN
SENOMYX, INC.
AND
THE COCA-COLA COMPANY
全文目录如下:
详细内容见附件
4.1 Formation of Steering Committee
4.2 Role of Steering Committee
5.2 Implementation of Research Plan
5.3 Determination of Commercially Viable Enhancing Compound(s)
5.4 Notification of Selected Compound
5.5 KO Compounds and KO Related Compounds
6.2 Implementation of Development Plan
6.4 Costs of Regulatory Filings
6.5 Additional Safety Studies or Regulatory Approvals
7.2 Format of Commercialization Plan
8.5 Rights to a New High-Potency
9.2 Credit Toward Royalties During Collaborative R&D Period
9.4 Royalty for Beverages Incorporating Product Compounds
9.6 Adjustment of Values for Minimum Royalties
9.11 Records of Unit Sales, Net Sales and Royalty Calculations
10.1 Non-exclusive Grant by SENOMYX of Rights Regarding Evaluation of Enhancing Compounds
10.2 Non-exclusive Grant by SENOMYX of Rights to Make and Have Made Selected Compounds
10.6 Contingent Third Party Rights to Field II
10.8 If KO Does Not Pay Minimum Royalties
10.10 Obligations Related to Sublicenses
10.11 Non-exclusive Grant of Rights from KO to SENOMYX for Research Purposes
10.12 Non-exclusive Grant of Rights from KO to SENOMYX for KO Related Compounds
10.13 Exclusive Grant of Rights from KO to SENOMYX for KO Related Compounds
10.14 Non-Exclusive Grant of Rights to SENOMYX Trademark
11. OWNERSHIP OF INTELLECTUAL PROPERTY
11.7 Inventors hip and Assignment
12. PATENT PROSECUTION AND MAINTENANCE
12.2 Inventions under Collaboration
13. INTELLECTUAL PROPERTY ENFORCEMENT AND DEFENSE OF CLAIMS
13.1 Defense of Infringement Claims for SENOMYX Technology
13.2 Defense of Infringement Claims for KO Technology
14. TREATMENT OF CONFIDENTIAL INFORMATION: REPORTING REQUIREMENTS, PUBLICITY, LAW AND REGULATIONS
14.2 Disclosure to Related Parties
14.3 Return of Confidential Material
14.4 Exceptions to Confidential Information
14.5 Confidential Financial Information
14.6 Confidential Research Information
14.7 Permitted Use and Disclosures
14.8 Use of Data for Promotional Purposes
14.11 Reporting, Law and Regulation
15. TERM, EARLY CONCLUSION, AND TERMINATION
15.2 Early Conclusion of the Collaborative R&D Period by KO
15.3 Termination By Mutual Agreement
15.4 Termination By KO for Acquisition of SENOMYX By a KO Competitor
16. WARRANTIES AND INDEMNIFICATION
16.1 Mutual Representations and Warranties
16.5 Warranties Regarding SENOMYX Technology
16.6 Warranties Relating to KO Technology
17.2 Governing Law and Jurisdiction
17.12 No Third Party Beneficiaries